AtriCure, Inc. (ATRC)
USD 34.22
(1.3%)
USD 34.22
(1.3%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 67.89 Million USD | 47.82% |
| 2022 | 45.93 Million USD | 17.88% |
| 2021 | 38.96 Million USD | 11.24% |
| 2020 | 35.02 Million USD | 19.08% |
| 2019 | 29.41 Million USD | 30.82% |
| 2018 | 22.48 Million USD | 0.15% |
| 2017 | 22.45 Million USD | 27.13% |
| 2016 | 17.66 Million USD | 0.01% |
| 2015 | 17.65 Million USD | 23.86% |
| 2014 | 14.25 Million USD | 39.58% |
| 2013 | 10.21 Million USD | 78.63% |
| 2012 | 5.71 Million USD | -12.88% |
| 2011 | 6.56 Million USD | 15.55% |
| 2010 | 5.68 Million USD | 16.64% |
| 2009 | 4.86 Million USD | -23.45% |
| 2008 | 6.36 Million USD | 20.79% |
| 2007 | 5.26 Million USD | 55.37% |
| 2006 | 3.38 Million USD | 58.74% |
| 2005 | 2.13 Million USD | 96.35% |
| 2004 | 1.08 Million USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 73.65 Million USD | 2.38% |
| 2024 Q1 | 71.94 Million USD | 5.96% |
| 2024 Q3 | 76.54 Million USD | 3.93% |
| 2023 Q3 | 61.89 Million USD | 11.7% |
| 2023 Q4 | 67.89 Million USD | 9.7% |
| 2023 FY | 67.89 Million USD | 47.82% |
| 2023 Q1 | 48.84 Million USD | 6.35% |
| 2023 Q2 | 55.4 Million USD | 13.43% |
| 2022 Q4 | 45.93 Million USD | 4.5% |
| 2022 Q1 | 40.76 Million USD | 4.61% |
| 2022 Q3 | 43.95 Million USD | 6.44% |
| 2022 FY | 45.93 Million USD | 17.88% |
| 2022 Q2 | 41.29 Million USD | 1.3% |
| 2021 FY | 38.96 Million USD | 11.24% |
| 2021 Q1 | 36.14 Million USD | 3.19% |
| 2021 Q2 | 37.6 Million USD | 4.05% |
| 2021 Q3 | 38.58 Million USD | 2.6% |
| 2021 Q4 | 38.96 Million USD | 0.98% |
| 2020 Q2 | 32.8 Million USD | 2.33% |
| 2020 FY | 35.02 Million USD | 19.08% |
| 2020 Q1 | 32.06 Million USD | 9.01% |
| 2020 Q4 | 35.02 Million USD | 2.04% |
| 2020 Q3 | 34.32 Million USD | 4.62% |
| 2019 Q2 | 24.43 Million USD | 1.29% |
| 2019 FY | 29.41 Million USD | 30.82% |
| 2019 Q1 | 24.12 Million USD | 7.29% |
| 2019 Q4 | 29.41 Million USD | 5.85% |
| 2019 Q3 | 27.78 Million USD | 13.74% |
| 2018 Q3 | 22.25 Million USD | 2.66% |
| 2018 FY | 22.48 Million USD | 0.15% |
| 2018 Q4 | 22.48 Million USD | 1.02% |
| 2018 Q2 | 21.68 Million USD | -3.94% |
| 2018 Q1 | 22.57 Million USD | 0.53% |
| 2017 Q3 | 22.56 Million USD | 13.15% |
| 2017 Q4 | 22.45 Million USD | -0.51% |
| 2017 Q1 | 18.83 Million USD | 6.67% |
| 2017 FY | 22.45 Million USD | 27.13% |
| 2017 Q2 | 19.94 Million USD | 5.87% |
| 2016 Q4 | 17.66 Million USD | -6.98% |
| 2016 Q3 | 18.98 Million USD | -1.69% |
| 2016 Q2 | 19.31 Million USD | 1.56% |
| 2016 Q1 | 19.01 Million USD | 7.68% |
| 2016 FY | 17.66 Million USD | 0.01% |
| 2015 Q4 | 17.65 Million USD | 6.59% |
| 2015 Q1 | 15.1 Million USD | 5.95% |
| 2015 Q2 | 16.07 Million USD | 6.4% |
| 2015 Q3 | 16.56 Million USD | 3.07% |
| 2015 FY | 17.65 Million USD | 23.86% |
| 2014 Q3 | 14.56 Million USD | 14.98% |
| 2014 Q1 | 11.08 Million USD | 8.5% |
| 2014 FY | 14.25 Million USD | 39.58% |
| 2014 Q2 | 12.66 Million USD | 14.29% |
| 2014 Q4 | 14.25 Million USD | -2.1% |
| 2013 Q2 | 6.02 Million USD | 5.88% |
| 2013 Q4 | 10.21 Million USD | 44.63% |
| 2013 FY | 10.21 Million USD | 78.63% |
| 2013 Q1 | 5.69 Million USD | -0.44% |
| 2013 Q3 | 7.06 Million USD | 17.15% |
| 2012 Q4 | 5.71 Million USD | -16.87% |
| 2012 Q2 | 6.49 Million USD | -7.76% |
| 2012 Q1 | 7.03 Million USD | 7.22% |
| 2012 FY | 5.71 Million USD | -12.88% |
| 2012 Q3 | 6.87 Million USD | 5.96% |
| 2011 FY | 6.56 Million USD | 15.55% |
| 2011 Q4 | 6.56 Million USD | 0.31% |
| 2011 Q3 | 6.54 Million USD | 8.88% |
| 2011 Q2 | 6 Million USD | -0.1% |
| 2011 Q1 | 6.01 Million USD | 5.9% |
| 2010 Q1 | 5.44 Million USD | 11.9% |
| 2010 FY | 5.68 Million USD | 16.64% |
| 2010 Q4 | 5.68 Million USD | -14.35% |
| 2010 Q3 | 6.63 Million USD | 10.73% |
| 2010 Q2 | 5.98 Million USD | 9.91% |
| 2009 Q3 | 5.47 Million USD | -7.65% |
| 2009 FY | 4.86 Million USD | -23.45% |
| 2009 Q1 | 5.69 Million USD | -10.54% |
| 2009 Q2 | 5.93 Million USD | 4.24% |
| 2009 Q4 | 4.86 Million USD | -11.11% |
| 2008 Q2 | 5.84 Million USD | -7.25% |
| 2008 FY | 6.36 Million USD | 20.79% |
| 2008 Q4 | 6.36 Million USD | 18.71% |
| 2008 Q3 | 5.35 Million USD | -8.36% |
| 2008 Q1 | 6.3 Million USD | 19.73% |
| 2007 Q4 | 5.26 Million USD | 26.22% |
| 2007 Q2 | 3.97 Million USD | -3.39% |
| 2007 Q1 | 4.11 Million USD | 21.43% |
| 2007 FY | 5.26 Million USD | 55.37% |
| 2007 Q3 | 4.17 Million USD | 4.93% |
| 2006 FY | 3.38 Million USD | 58.74% |
| 2006 Q1 | 2.7 Million USD | 26.85% |
| 2006 Q3 | 3.24 Million USD | 6.35% |
| 2006 Q2 | 3.05 Million USD | 12.82% |
| 2006 Q4 | 3.38 Million USD | 4.3% |
| 2005 Q2 | 1.55 Million USD | 47.83% |
| 2005 Q4 | 2.13 Million USD | -11.94% |
| 2005 Q1 | 1.05 Million USD | -3.41% |
| 2005 Q3 | 2.42 Million USD | 56.15% |
| 2005 FY | 2.13 Million USD | 96.35% |
| 2004 FY | 1.08 Million USD | 0.0% |
| 2004 Q4 | 1.08 Million USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | -279.801% |
| AngioDynamics, Inc. | 60.61 Million USD | -12.012% |
| Avinger, Inc. | 5.29 Million USD | -1181.559% |
| Azenta, Inc. | 128.19 Million USD | 47.037% |
| BioLife Solutions, Inc. | 43.45 Million USD | -56.243% |
| The Cooper Companies, Inc. | 735.6 Million USD | 90.77% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | -1244.495% |
| Femasys Inc. | 667.11 Thousand USD | -10077.66% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | -174.709% |
| Hologic, Inc. | 679.8 Million USD | 90.012% |
| ICU Medical, Inc. | 709.36 Million USD | 90.428% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 94.437% |
| KORU Medical Systems, Inc. | 3.48 Million USD | -1850.334% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | -29.74% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -7824.866% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -7824.866% |
| Masimo Corporation | 545 Million USD | 87.542% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -4098.364% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 77.656% |
| Nephros, Inc. | 2.47 Million USD | -2648.866% |
| NovoCure Limited | 38.15 Million USD | -77.964% |
| NEXGEL, Inc. | 1.31 Million USD | -5047.612% |
| NEXGEL, Inc. | 1.31 Million USD | -5047.612% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | -400.273% |
| OraSure Technologies, Inc. | 47.61 Million USD | -42.599% |
| Pro-Dex, Inc. | 15.26 Million USD | -344.672% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -13633.934% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | -2267.316% |
| QuidelOrtho Corporation | 577.8 Million USD | 88.249% |
| Repligen Corporation | 202.32 Million USD | 66.441% |
| Sanara MedTech Inc. | 4.71 Million USD | -1339.248% |
| STAAR Surgical Company | 35.13 Million USD | -93.274% |
| Sharps Technology, Inc. | 1.7 Million USD | -3872.594% |
| Utah Medical Products, Inc. | 9.58 Million USD | -608.589% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 89.119% |
| Jin Medical International Ltd. | 5.05 Million USD | -1243.661% |